147 related articles for article (PubMed ID: 22425983)
1. VCC-1 over-expression inhibits cisplatin-induced apoptosis in HepG2 cells.
Zhou Z; Lu X; Zhu P; Zhu W; Mu X; Qu R; Li M
Biochem Biophys Res Commun; 2012 Apr; 420(2):336-42. PubMed ID: 22425983
[TBL] [Abstract][Full Text] [Related]
2. Cisplatin-induced downregulation of miR-199a-5p increases drug resistance by activating autophagy in HCC cell.
Xu N; Zhang J; Shen C; Luo Y; Xia L; Xue F; Xia Q
Biochem Biophys Res Commun; 2012 Jul; 423(4):826-31. PubMed ID: 22713463
[TBL] [Abstract][Full Text] [Related]
3. No correlation between the expression of FXR and genes involved in multidrug resistance phenotype of primary liver tumors.
Martinez-Becerra P; Vaquero J; Romero MR; Lozano E; Anadon C; Macias RI; Serrano MA; Grañé-Boladeras N; Muñoz-Bellvis L; Alvarez L; Sangro B; Pastor-Anglada M; Marin JJ
Mol Pharm; 2012 Jun; 9(6):1693-704. PubMed ID: 22524153
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of the JNK signaling pathway increases sensitivity of hepatocellular carcinoma cells to cisplatin by down-regulating expression of P-glycoprotein.
Liu XY; Liu SP; Jiang J; Zhang X; Zhang T
Eur Rev Med Pharmacol Sci; 2016; 20(6):1098-108. PubMed ID: 27049263
[TBL] [Abstract][Full Text] [Related]
5. Upregulated miR-182 increases drug resistance in cisplatin-treated HCC cell by regulating TP53INP1.
Qin J; Luo M; Qian H; Chen W
Gene; 2014 Apr; 538(2):342-7. PubMed ID: 24447717
[TBL] [Abstract][Full Text] [Related]
6. Expression of zinc finger 23 gene in human hepatocellular carcinoma.
Shi Y; Zheng L; Luo G; Wei J; Zhang J; Yu Y; Feng Y; Li M; Xu N
Anticancer Res; 2011 Oct; 31(10):3595-9. PubMed ID: 21965783
[TBL] [Abstract][Full Text] [Related]
7. Characterization of cell death events induced by anti-neoplastic drugs cisplatin, paclitaxel and 5-fluorouracil on human hepatoma cell lines: Possible mechanisms of cell resistance.
Brenes O; Arce F; Gätjens-Boniche O; Díaz C
Biomed Pharmacother; 2007 Jul; 61(6):347-55. PubMed ID: 17399942
[TBL] [Abstract][Full Text] [Related]
8. Resistance to cisplatin-induced apoptosis via PI3K-dependent survivin expression in a rat hepatoma cell line.
Asechi H; Hatano E; Nitta T; Tada M; Iwaisako K; Tamaki N; Nagata H; Narita M; Yanagida A; Ikai I; Uemoto S
Int J Oncol; 2010 Jul; 37(1):89-96. PubMed ID: 20514400
[TBL] [Abstract][Full Text] [Related]
9. TIP30 mutant derived from hepatocellular carcinoma specimens promotes growth of HepG2 cells through up-regulation of N-cadherin.
Jiang C; Pecha J; Hoshino I; Ankrapp D; Xiao H
Cancer Res; 2007 Apr; 67(8):3574-82. PubMed ID: 17440068
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA profiles in cisplatin-induced apoptosis of hepatocellular carcinoma cells.
Miyata M; Morishita A; Sakamoto T; Katsura A; Kato K; Nishioka T; Toyota Y; Fujita K; Maeda E; Nomura T; Tani J; Miyoshi H; Yoneyama H; Kobara H; Fujiwara S; Nishiyama N; Iwama H; Himoto T; Hirashima M; Masaki T
Int J Oncol; 2015 Aug; 47(2):535-42. PubMed ID: 26060089
[TBL] [Abstract][Full Text] [Related]
11. Dexamethasone decreases hepatocellular carcinoma cell sensitivity to cisplatin-induced apoptosis.
Yang N; Zhang H; Si-Ma H; Fu Y; Zhao W; Li D; Yang G
Hepatogastroenterology; 2011; 58(110-111):1730-5. PubMed ID: 21940343
[TBL] [Abstract][Full Text] [Related]
12. Protective effects of hepatic stellate cells against cisplatin-induced apoptosis in human hepatoma G2 cells.
Zhang L; Li Y; Qiao L; Zhao Y; Wei Y; Li Y
Int J Oncol; 2015 Aug; 47(2):632-40. PubMed ID: 26035065
[TBL] [Abstract][Full Text] [Related]
13. [Antiproliferative effects mechanism of beta-sitosterul in hepatoma HepG2 cells].
Zhang Z; Xing Y; Hu G; Xie S
Zhongguo Zhong Yao Za Zhi; 2011 Aug; 36(15):2145-8. PubMed ID: 22066458
[TBL] [Abstract][Full Text] [Related]
14. Apigenin inhibits hepatoma cell growth through alteration of gene expression patterns.
Cai J; Zhao XL; Liu AW; Nian H; Zhang SH
Phytomedicine; 2011 Mar; 18(5):366-73. PubMed ID: 20850954
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of miR-363 increases drug resistance in cisplatin-treated HepG2 by dysregulating Mcl-1.
Ou Y; Zhai D; Wu N; Li X
Gene; 2015 Nov; 572(1):116-122. PubMed ID: 26143754
[TBL] [Abstract][Full Text] [Related]
16. Vigilin is overexpressed in hepatocellular carcinoma and is required for HCC cell proliferation and tumor growth.
Yang WL; Wei L; Huang WQ; Li R; Shen WY; Liu JY; Xu JM; Li B; Qin Y
Oncol Rep; 2014 May; 31(5):2328-34. PubMed ID: 24676454
[TBL] [Abstract][Full Text] [Related]
17. FBI-1 promotes cell proliferation and enhances resistance to chemotherapy of hepatocellular carcinoma in vitro and in vivo.
Fang F; Yang L; Tao Y; Qin W
Cancer; 2012 Jan; 118(1):134-46. PubMed ID: 21713761
[TBL] [Abstract][Full Text] [Related]
18. Synergistic growth-suppressive effects of quercetin and cisplatin on HepG2 human hepatocellular carcinoma cells.
Zhao JL; Zhao J; Jiao HJ
Appl Biochem Biotechnol; 2014 Jan; 172(2):784-91. PubMed ID: 24122665
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of fractalkine inhibits the in vitro and in vivo angiogenesis of the hepatocellular carcinoma HepG2 cells.
Li F; Wang Z; Liu Y; Li J
Oncol Rep; 2010 Sep; 24(3):669-75. PubMed ID: 20664972
[TBL] [Abstract][Full Text] [Related]
20. Leucine-rich protein 130 contributes to apoptosis resistance of human hepatocarcinoma cells.
Michaud M; Barakat S; Magnard S; Rigal D; Baggetto LG
Int J Oncol; 2011 Jan; 38(1):169-78. PubMed ID: 21109938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
